Results 11 to 20 of about 447,676 (302)

Growth Hormone Therapy in Adults

open access: yesEndocrinology Research and Practice, 2022
Adult growth hormone deficiency (GHD) has come to be accepted as a clinical syndrome (or nearly past 10 years. Based on increasing evidence that adults with GHD have impaired health, many countries have already approved the use of growth hormone (GH) for
Vedia Tonyukuk, Demet Çorapçıoğlu
doaj   +2 more sources

A Case Series Study on Growth Hormone Therapy in Children with Prader-Willi Syndrome in Portugal

open access: yesActa Médica Portuguesa, 2022
Introduction: Prader-Willi syndrome is a multisystemic genetic disorder associated with shorter adult height. Nowadays, all paediatric Prader-Willi syndrome patients are considered for growth hormone treatment.
Madalena Meira Nisa   +7 more
doaj   +1 more source

Hedgehog Signalling in Androgen Independent Prostate Cancer [PDF]

open access: yes, 2008
Objectives: Androgen-deprivation therapy effectively shrinks hormone-naïve prostate cancer, both in the prostate and at sites of distant metastasis.
Bisson, Isabelle   +7 more
core   +1 more source

Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement [PDF]

open access: yes, 2016
Until quite recently, the management of children with growth hormone deficiency (GHD) had focussed on the use of recombinant human GH (rhGH) therapy to normalise final adult height.
Ahmed, S.F.   +3 more
core   +2 more sources

Anophthalmia, hearing loss, abnormal pituitary development and response to growth hormone therapy in three children with microdeletions of 14q22q23 [PDF]

open access: yes, 2014
BACKGROUND: Microdeletions of 14q22q23 have been associated with eye abnormalities and pituitary defects. Other phenotypic features in deletion carriers including hearing loss and response to growth hormone therapy are less well recognized.
Audrey Briand-Suleau   +14 more
core   +3 more sources

Effects of long-term growth hormone therapy in a girl with Floating-Harbor syndrome [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2020
Floating-Harbor syndrome is a rare autosomal dominant disorder that presents with short stature, facial dysmorphism, significantly delayed bone age, skeletal abnormalities, speech and language problems, and intellectual disabilities.
Hyun Woo Son   +4 more
doaj   +1 more source

Quality of life and cognitive function in patients with pituitary insufficiency [PDF]

open access: yes, 1998
This review is concerned with the psychosocial functioning and the quality of life in patients with pituitary insufficiency who are receiving conventional hormone replacement therapy.
Burman, P., Deijen, J.B.
core   +1 more source

Growth Hormone Deficiency in the Transition Period

open access: yesEndocrinology Research and Practice, 2019
The importance of continuing growth hormone therapy in the transition and adulthood periods must be studied in adolescents with growth hormone deficiency with childhood onset.
Doğuş VURALLI
doaj   +1 more source

Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency

open access: yesJournal of the Formosan Medical Association, 2012
Human growth hormone (GH) has been successfully used in children with GH deficiency (GHD). However, there are few published data on the effect of GH in Taiwanese children with GHD.
Ying-Hua Huang   +3 more
doaj   +1 more source

Optimizing Patient Management and Adherence for Children Receiving Growth Hormone. [PDF]

open access: yes, 2017
Poor adherence with growth hormone (GH) therapy has been associated with worse clinical outcomes, which in children relates specifically to their linear growth and loss of quality of life.
Carlo L. Acerini   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy